Kim, N.; Lee, S.; Kang, J.; Choi, Y.-A.; Jang, Y.H.; Jeong, G.-S.; Kim, S.-H.
Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways. Molecules 2021, 26, 6086.
https://doi.org/10.3390/molecules26196086
AMA Style
Kim N, Lee S, Kang J, Choi Y-A, Jang YH, Jeong G-S, Kim S-H.
Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways. Molecules. 2021; 26(19):6086.
https://doi.org/10.3390/molecules26196086
Chicago/Turabian Style
Kim, Namkyung, Soyoung Lee, Jinjoo Kang, Young-Ae Choi, Yong Hyun Jang, Gil-Saeng Jeong, and Sang-Hyun Kim.
2021. "Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways" Molecules 26, no. 19: 6086.
https://doi.org/10.3390/molecules26196086
APA Style
Kim, N., Lee, S., Kang, J., Choi, Y.-A., Jang, Y. H., Jeong, G.-S., & Kim, S.-H.
(2021). Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways. Molecules, 26(19), 6086.
https://doi.org/10.3390/molecules26196086